Company Filing History:
1 out of 3 
1 out of 7 
1 out of 2 Years Active: 2022-2025
Title: **Chen Dong: Innovator in Immunotherapy**
Introduction
Chen Dong, a notable inventor based in Cupertino, CA, is recognized for his significant contributions to the fields of immunology and biopharmaceuticals. With a total of two patents, Dong's innovative work focuses on enhancing immune responses and developing treatments for various diseases, including cancer.
Latest Patents
Dong's most recent patents showcase his pioneering efforts in immunotherapy. The first patent, titled "CD80 variant proteins and uses thereof," provides a novel approach to creating variant CD80 polypeptides. These polypeptides exhibit altered affinities for their cognate binding partners, allowing for the development of immunomodulatory fusion proteins. This innovation opens new avenues for pharmaceutical compositions that can modulate immune responses and treat a range of conditions, including cancer and infectious diseases.
The second patent, concerning "Anti-claudin 18.2 antibodies," introduces valuable anti-claudin 18.2 (CLDN18.2) antibodies and their fragments. This patent also includes isolated nucleic acid molecules that encode these antibodies, along with vectors and host cells suitable for their production. The methods described in this patent aim to facilitate the treatment of disorders linked to aberrant CLDN18.2 expression, particularly various cancers.
Career Highlights
Throughout his career, Chen Dong has made notable strides in biopharmaceutical research and development. He has worked with prominent organizations, including Beijing Xuanyi Pharmasciences Co., Ltd. and Xuanzhu Biopharmaceutical Co., Ltd., where he has leveraged his expertise to drive advancements in therapeutic solutions.
Collaborations
Dong has collaborated with fellow researchers such as Yuntao Song and Ping Hui Szu, contributing to a dynamic environment of innovation and discovery in the biopharmaceutical sector. His partnerships reflect a commitment to advancing healthcare through collaborative efforts.
Conclusion
Chen Dong's contributions to immunotherapy and biopharmaceuticals exemplify the spirit of innovation. With his cutting-edge patents and collaborative work, Dong is poised to make significant impacts in the treatment of immune-related conditions, reinforcing the importance of drug development in modern medicine.